Brian Jones

Brian Jones

Company: Cedilla Therapeutics

Job title: Chief Scientific Officer


TEAD & The HIPPO Pathway 3:00 pm

• TEAD (Transcriptional Enhanced Associate Domain) is an important component of the Hippo signalling system, which is dysregulated in solid malignancies including mesothelioma and several squamous cell carcinomas • TEAD is also being linked to the development of resistance to targeted therapy, such as those for EGFR-mutated and KRAS-mutated lung cancerRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.